Angelica Macauda
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance.
Journal: International journal of cancer
Published: October 31, 2025
Genetically determined telomere length in monoclonal gammopathy of undetermined significance, multiple myeloma risk and outcome.
Journal: Blood cancer journal
Published: July 15, 2024
Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional characterization.
Journal: International journal of cancer
Published: April 04, 2024
Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?
Journal: International journal of molecular sciences
Published: March 12, 2023
Identification of novel genetic loci for risk of multiple myeloma by functional annotation.
Journal: Leukemia
Published: March 08, 2023
Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization.
Journal: International journal of molecular sciences
Published: March 04, 2023
GWAS-Identified Variants for Obesity Do Not Influence the Risk of Developing Multiple Myeloma: A Population-Based Study and Meta-Analysis.
Journal: International journal of molecular sciences
Published: February 25, 2023
Genome-wide study of genetic polymorphisms predictive for outcome from first-line oxaliplatin-based chemotherapy in colorectal cancer patients.
Journal: International journal of cancer
Published: December 02, 2022
Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: January 13, 2022
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk.
Journal: International journal of cancer
Published: December 07, 2021
Last Updated: 09/26/2026